342 related articles for article (PubMed ID: 24645664)
1. The kidney in Fabry's disease.
Pisani A; Visciano B; Imbriaco M; Di Nuzzi A; Mancini A; Marchetiello C; Riccio E
Clin Genet; 2014 Oct; 86(4):301-9. PubMed ID: 24645664
[TBL] [Abstract][Full Text] [Related]
2. Diagnosing Fabry nephropathy: the challenge of multiple kidney disease.
Esposito P; Caputo C; Repetto M; Somaschini A; Pietro B; Colomba P; Zizzo C; Parodi A; Zanetti V; Canepa M; Eustachi V; Sanguineri F; Mandich P; Viazzi F
BMC Nephrol; 2023 Nov; 24(1):344. PubMed ID: 37990184
[TBL] [Abstract][Full Text] [Related]
3. [Fabry's disease (alpha-galactosidase-A deficiency): recent therapeutic innovations].
Germain DP
J Soc Biol; 2002; 196(2):183-90. PubMed ID: 12360747
[TBL] [Abstract][Full Text] [Related]
4. Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.
Breunig F; Wanner C
J Nephrol; 2008; 21(1):32-7. PubMed ID: 18264934
[TBL] [Abstract][Full Text] [Related]
5. [A case of Fabry's disease with chronic renal failure].
Suzuki T; Fujino T; Sugasawa M; Kohara Y; Toyama K; Sato T; Yasuda T; Sugiyama M; Maeba T; Owada S; Ishida M
Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):448-53. PubMed ID: 10441995
[TBL] [Abstract][Full Text] [Related]
6. [Fabry's disease (alpha-galactosidase-A deficiency): physiopathology, clinical signs, and genetic aspects].
Germain DP
J Soc Biol; 2002; 196(2):161-73. PubMed ID: 12360745
[TBL] [Abstract][Full Text] [Related]
7. Case report: enzyme replacement therapy for Fabry disease presenting with proteinuria and ventricular septal thickening.
Chen Z; Yin B; Jiao J; Ye T
BMC Nephrol; 2024 Feb; 25(1):61. PubMed ID: 38383316
[TBL] [Abstract][Full Text] [Related]
8. Fabry disease.
Germain DP
Orphanet J Rare Dis; 2010 Nov; 5():30. PubMed ID: 21092187
[TBL] [Abstract][Full Text] [Related]
9. Renal involvement in Fabry's disease.
Okuda S
Intern Med; 2000 Aug; 39(8):601-2. PubMed ID: 10939529
[No Abstract] [Full Text] [Related]
10. [Enzyme replacement therapy in Fabry's disease].
Alvarez L; del Pozo C; Trigueros M; Sánchez L; Albero MD; López-Menchero R; Ortega E
Nefrologia; 2005; 25(3):322-7. PubMed ID: 16053014
[TBL] [Abstract][Full Text] [Related]
11. Fabry disease: molecular genetics of the inherited nephropathy.
Desnick RJ; Astrin KH; Bishop DF
Adv Nephrol Necker Hosp; 1989; 18():113-27. PubMed ID: 2564247
[TBL] [Abstract][Full Text] [Related]
12. Fabry disease in patients with end-stage renal failure: the potential benefits of screening.
Bekri S; Enica A; Ghafari T; Plaza G; Champenois I; Choukroun G; Unwin R; Jaeger P
Nephron Clin Pract; 2005; 101(1):c33-8. PubMed ID: 15886492
[TBL] [Abstract][Full Text] [Related]
13. [Fabry disease--a provocation for pediatrics].
Hoffmann B; Mayatepek E
Klin Padiatr; 2006; 218(1):38-40. PubMed ID: 16432775
[TBL] [Abstract][Full Text] [Related]
14. Complement activation and cellular inflammation in Fabry disease patients despite enzyme replacement therapy.
Laffer B; Lenders M; Ehlers-Jeske E; Heidenreich K; Brand E; Köhl J
Front Immunol; 2024; 15():1307558. PubMed ID: 38304433
[TBL] [Abstract][Full Text] [Related]
15. Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the alpha-galactosidase A gene.
Garzuly F; Maródi L; Erdös M; Grubits J; Varga Z; Gelpi E; Rohonyi B; Mázló M; Molnár A; Budka H
Brain; 2005 Sep; 128(Pt 9):2078-83. PubMed ID: 15947062
[TBL] [Abstract][Full Text] [Related]
16. Subclinical Fabry's disease occurring in the context of IgA nephropathy.
Kawamura O; Sakuraba H; Itoh K; Suzuki Y; Doi M; Kuwabara H; Oshima S; Abe S; Warabi H; Yoshizawa N
Clin Nephrol; 1997 Feb; 47(2):71-5. PubMed ID: 9049452
[TBL] [Abstract][Full Text] [Related]
17. Enzyme replacement therapy for Fabry disease, an inherited nephropathy.
Desnick RJ; Banikazemi M; Wasserstein M
Clin Nephrol; 2002 Jan; 57(1):1-8. PubMed ID: 11837797
[TBL] [Abstract][Full Text] [Related]
18. Correlation of X chromosome inactivation with clinical presentation of Fabry disease in a case report.
Rodríguez Doyágüez P; Furlano M; Ars Criach E; Arce Y; Guirado L; Torra Balcells R
Nefrologia (Engl Ed); 2023 Dec; 43 Suppl 2():91-95. PubMed ID: 38278716
[TBL] [Abstract][Full Text] [Related]
19. [Visceral manifestations of glycosphingolipidosis (Fabry's disease)].
Zaĭrat'iants OV; Bruk EI; Berestova AV; Mendel'son MM
Arkh Patol; 1987; 49(6):58-63. PubMed ID: 3117021
[TBL] [Abstract][Full Text] [Related]
20. [Fabry's disease; towards a treatment].
Linthorst GE; Hollak CE; Bosman DK; Heymans HS; Aerts JM
Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2391-5. PubMed ID: 11145093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]